Guanidine Hydrochloride

CHEMBL1200728 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
95.5 g/mol
LogP
Phase
4

A hydrochloride form of guanidine with the same therapeutic properties. Used experimentally in conditions affecting nerve-muscle signaling to help release acetylcholine at nerve endings.

Berat Molekul

95,5300 g/mol

TPSA

75,90 Ų

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.N=C(N)N

InChI

InChI=1S/CH5N3.ClH/c2-1(3)4;/h(H5,2,3,4);1H

Molecular Formula

CH6ClN3

HBD / HBA

4 / 1

Ikatan yang Dapat Dirotasi

0

Atom Berat

5

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A hydrochloride form of guanidine with the same therapeutic properties. Used experimentally in conditions affecting nerve-muscle signaling to help release acetylcholine at nerve endings.

Yes, Guanidine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200728. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5742. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.